Novartis Looks to Treat MS Patients Earlier With New Medicine

Bookmark
(Bloomberg) -- Novartis AG, the Swiss drugmaker, is seeking to reach as many as a quarter of a million U.S. patients with an advanced and debilitating form of multiple sclerosis after regulators cl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.